drugset / Trial / NCT00117182

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

NCT00117182

Phase 2 Completed 140 enrolled Syntara
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine whether the Aridol (mannitol) challenge test can predict response to treatment with inhaled corticosteroids in COPD subjects. Subjects will undergo an Aridol test and then 3 months of treatment with inhaled corticosteroids. The effect on lung function and quality of life will then be measured and correlated with the Aridol test result.

Timeline

Start
2005-07
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 400 ug Inhaled
Subject Mannitol Diagnostic / imaging agent
Background Ipratropium Small molecule 80 ug
Background Salbutamol Unknown 400 ug